Accipiter Biosciences
Accipiter Biosciences is a startup headquartered in Seattle, United States, founded in 2023. It has raised at least $13.6m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Accipiter Biosciences has raised at least $13.6m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Accipiter Biosciences sits inside the Seattle and Redmond R&D ecosystem in the Global R&D Labs Directory.
Other startups in Seattle
- 98point6 Technologies
- Adronite
- Aether Studios
- Aggro Crab
- Arrived Holdings
- AtmoCooling
- Automera US
- Better Science
- Bond Communications
- Bonum Therapeutics
- Caddi Technologies
Related
- Innovation profile of Seattle
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Accipiter Biosciences do?
Accipiter Biosciences is classed in technology in its filings with the US Securities and Exchange Commission.
How much has Accipiter Biosciences raised?
At least $13.6m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Accipiter Biosciences based?
Accipiter Biosciences is headquartered in Seattle, United States.
When was Accipiter Biosciences founded?
Accipiter Biosciences was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.